BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1456179)

  • 1. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
    Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
    Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
    Martins MA; Etienne A; Soulard C; Domingo MT; Braquet P
    Braz J Med Biol Res; 1989; 22(9):1151-4. PubMed ID: 2636011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
    Nabe T; Yamamura H; Kohno S
    Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of neutrophil and eosinophil chemotactic responses to PAF by the PAF-antagonists WEB-2086, L-652,731, and SRI-63441.
    HÃ¥kansson L; Venge P
    J Leukoc Biol; 1990 May; 47(5):449-56. PubMed ID: 2335754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ketotifen on eosinophils as measured at LTC4 release and by chemotaxis.
    Nabe M; Miyagawa H; Agrawal DK; Sugiyama H; Townley RG
    Allergy Proc; 1991; 12(4):267-71. PubMed ID: 1936977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
    J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
    Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK
    Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
    Tamura N; Agrawal DK; Townley RG
    J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation.
    Eda R; Sugiyama H; Hopp RJ; Okada C; Bewtra AK; Townley RG
    Int Arch Allergy Immunol; 1993; 102(4):391-8. PubMed ID: 8241801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
    Casale TB; Erger RA; Little MM
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
    Tamura N; Agrawal DK; Suliaman FA; Townley RG
    Biochem Biophys Res Commun; 1987 Feb; 142(3):638-44. PubMed ID: 3030295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
    Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
    Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
    J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
    Koike H; Imanishi N; Natsume Y; Morooka S
    Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
    Erger RA; Casale TB
    Am J Respir Cell Mol Biol; 1995 Jan; 12(1):65-70. PubMed ID: 7811471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nedocromil sodium and WEB 2086 on chemoattractant-stimulated neutrophil migration through cellular and noncellular barriers.
    Carolan EJ; Casale TB
    Ann Allergy; 1992 Oct; 69(4):323-8. PubMed ID: 1329582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
    Eda R; Townley RG; Hopp RJ
    Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Soyombo O; Spur BW; Lee TH
    Allergy; 1994 Apr; 49(4):230-4. PubMed ID: 8037356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming of eosinophil recruitment in vivo by LPS pretreatment.
    Macari DM; Teixeira MM; Hellewell PG
    J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of terfenadine on neutrophil and eosinophil chemotactic activities after inhalation of platelet-activating factor in vivo and on neutrophil chemotaxis in vitro.
    Okada C; Hopp RJ; Miyagawa H; Sugiyama H; Nair NM; Bewtra AK; Townley RG
    Int Arch Allergy Immunol; 1992; 97(3):181-6. PubMed ID: 1587633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.